Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

CoreAge Rx vs Goldspan Health

CoreAge Rx
Graded #1

Higher grade

vs+23.6
Goldspan Health
Graded #161

Lower grade

The verdict

CoreAge Rx takes it — 91.8/100 to 68.2/100.

CoreAge Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

CoreAge Rx is also our overall #1 pick — it tops the full scorecard at 91.8/100 (A−).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCoreAge Rx +56
92
36
Dose & formulationCoreAge Rx +13
88
75
Clinical oversightCoreAge Rx +16
93
77
Labs & monitoringGoldspan Health +7
90
97
FulfillmentCoreAge Rx +6
95
89
Contract termsCoreAge Rx +51
96
45
CoreAge Rx · left barGoldspan Health · right bar

The numbers

MetricCoreAge RxGoldspan Health
WeighScore91.8/10068.2/100
GradeA−C
Scorecard rank#1#161
Semaglutide$99/mo$229 per 28 days (a single plan; thirteen charges a year)
Tirzepatide$149/mo$299 per 28 days (a single plan; thirteen charges a year)
CoverageAll 50 statesAll 50 states plus Washington, D.C.
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
CoreAge Rx

Graded #1 · A−

Strengths

  • Flat all-in price with no month-two step-up
  • Semaglutide and tirzepatide on one account
  • All 50 states, LegitScript-verified

Where it loses points

  • Not the cheapest sticker price
  • Compounded only
  • Pharmacy partner not yet publicly named
Goldspan Health

Graded #161 · C

Strengths

  • One plan per molecule with no tier ladder to read, which removes the commonest source of a misquoted price
  • Sublingual full-dose and microdose lines sit alongside the injections for readers who will not inject
  • States its compounding class — dispensed by a pharmacy licensed under 503A or 503B — rather than leaving it unsaid
  • Names a medical director and two clinical advisors by name and specialty
  • A lab panel is genuinely required at 60 to 90 days and annually after that, which is stronger monitoring than most of this ranking asks for

Where it loses points

  • The required lab panel is described as available at a low cost and its cost is stated nowhere on the site
  • The hero says “/month”, the plan card says billed every 28 days and the order timeline says every four weeks — thirteen charges a year, not twelve
  • “Pause, delay, or cancel at any time” on the storefront sits against a refund policy reading “all sales are final” and platform terms saying an order cannot be canceled once placed
  • The tirzepatide sublingual microdose page lists compounded sublingual semaglutide microdose in its own inclusion list
  • Clinicians are attributed to a partner platform while the storefront states it is not a medical practice
  • No pharmacy is named, and Goldspan publishes no legal entity, address or governing law of its own
  • Full-dose sublingual products exist on the catalog and are not linked from the site's own weight-loss page

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard